Board of Directors

Tomas Mustelin, MD PhD
Independent Board Member
Tomas is a leading clinician-scientist with extensive experience. Tomas has worked at Amgen, Gilead and MedImmune in leadership roles and has guided a number of new drugs through the drug development process. Tomas received his MD and PhD from the University of Helsinki.